Filing Details

Accession Number:
0001140361-15-037812
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-16 10:17:54
Reporting Period:
2015-05-07
Filing Date:
2015-10-16
Accepted Time:
2015-10-16 10:17:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578767 Michael William Kavanaugh 343 Oyster Point Blvd.
Suite 100
South San Francisco CA 94080
Cso, Head Res.&Non-Clin. Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-14 5,000 $12.00 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2015-05-07 246,042 $0.00 246,042 $1.57
Common Stock Emploiyee Stock Option (right to buy) Acquisiton 2015-08-26 85,605 $0.00 85,605 $6.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
246,042 2025-02-08 No 4 A Direct
85,605 2025-08-25 No 4 A Direct
Footnotes
  1. This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.
  2. This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.